Free Trial
ASX:MVP

Medical Developments International (MVP) Stock Price, News & Analysis

Medical Developments International logo

About Medical Developments International Stock (ASX:MVP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
169,499 shs
Average Volume
N/A
Market Capitalization
$98.01 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Receive MVP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter.

MVP Stock News Headlines

The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
See More Headlines

MVP Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Developments International investors own include Core Lithium (CXO), Bubs Australia (BUB), Talon Energy (TPD), Qantas Airways (QAN), Mesoblast (MESO), LINE (LN) and Harvey Norman (HVN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:MVP
CIK
N/A
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.99 million
Net Margins
-123.66%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$33.15 million
Price / Cash Flow
21.37
Book Value
A$0.52 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$98.01 million
Optionable
Not Optionable
Beta
1.63
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (ASX:MVP) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners